<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: antigens</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Researchers Build Artificial Immune System to Solve Computational Problems</title>
   	 <description>(PhysOrg.com) -- By mimicking the way that a living body acquires immunity to disease through vaccination, researchers have designed an artificial immune system to solve optimization problems more effectively than before. The results show that the biologically motivated approach is better at exploring a greater amount of space and quickly locating the desired local and global optima than previous methods.</description>
     <link>http://www.physorg.com/news179060729.html</link>
	 <category>Technology</category>
	 <pubDate>Thu, 03 Dec 2009 11:05:59 EST</pubDate>
	 <guid isPermaLink="false">news179060729</guid>
</item>
<item>
     <title>Implant-based cancer vaccine is first to eliminate tumors in mice</title>
   	 <description>(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal Science Translational Medicine.</description>
     <link>http://www.physorg.com/news178382282.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 25 Nov 2009 14:38:42 EST</pubDate>
	 <guid isPermaLink="false">news178382282</guid>
</item>
<item>
     <title>The difficult Way to HIV Vaccine</title>
   	 <description>T cells are key players in the immune response to HIV, which are able to delete infected cells. This capacity is used for vaccine development against HIV. `To date however, success of this strategy remains elusive. Our understanding of T cell efficacy is still limited, and we need to identify precise T cell correlates of protection that could guide rationale vaccine design`, says Victor Appay, Group leader HIV Pathogenesis and Immunosenescence, Hopital Pitie-Salpetriere, Paris, at the 2nd European Congress of Immunology ECI 2009 in Berlin.</description>
     <link>http://www.physorg.com/news172316676.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 16 Sep 2009 11:00:01 EST</pubDate>
	 <guid isPermaLink="false">news172316676</guid>
</item>
<item>
     <title>New 'adjuvant' could hold future of vaccine development</title>
   	 <description>Scientists at Oregon State University have developed a new "adjuvant" that could allow the creation of important new vaccines, possibly become a universal vaccine carrier and help medical experts tackle many diseases more effectively.</description>
     <link>http://www.physorg.com/news172171724.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 14 Sep 2009 18:40:02 EST</pubDate>
	 <guid isPermaLink="false">news172171724</guid>
</item>
<item>
     <title>Prodrug could help curb skin toxicity related to EGFR-inhibiting cancer drugs</title>
   	 <description>There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.</description>
     <link>http://www.physorg.com/news171026841.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Sep 2009 12:27:57 EST</pubDate>
	 <guid isPermaLink="false">news171026841</guid>
</item>
<item>
     <title>On the move: 'Jumping genes' create diversity in human brain cells</title>
   	 <description>Rather than sticking to a single DNA script, human brain cells harbor astonishing genomic variability, according to scientists at the Salk Institute for Biological Studies. The findings, to be published in the Aug. 5, 2009, advance online edition of Nature, could help explain brain development and individuality, as well as lead to a better understanding of neurological disease.</description>
     <link>http://www.physorg.com/news168697506.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 05 Aug 2009 13:25:34 EST</pubDate>
	 <guid isPermaLink="false">news168697506</guid>
</item>
<item>
     <title>An advance in solving the mysterious machine-workers' disease</title>
   	 <description>Scientists in Ohio are reporting a long-awaited advance toward making the workplace safer for more than one million machinists in the United States who may be exposed to disease-causing bacteria in contaminated metalworking fluids. Those fluids become airborne during machining of metal parts. The study appears in the current edition of ACS` monthly Journal of Proteome Research.</description>
     <link>http://www.physorg.com/news162060407.html</link>
	 <category>Chemistry</category>
	 <pubDate>Wed, 20 May 2009 17:47:18 EST</pubDate>
	 <guid isPermaLink="false">news162060407</guid>
</item>
<item>
     <title>New evidence explains poor infant immune response to certain vaccines</title>
   	 <description>For years, researchers and physicians have known that infants' immune systems do not respond well to certain vaccines, thus the need for additional boosters as children develop. Now, in a new study from the University of Missouri, one researcher has found an explanation for that poor response. In the study, the MU scientist found evidence that the immune systems of newborns might require some time after birth to mature to a point where the benefits of vaccines can be fully realized.</description>
     <link>http://www.physorg.com/news157817036.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Apr 2009 15:04:22 EST</pubDate>
	 <guid isPermaLink="false">news157817036</guid>
</item>
<item>
     <title>Implants mimic infection to rally immune system against tumors</title>
   	 <description>Bioengineers at Harvard University have shown that small plastic disks impregnated with tumor-specific antigens and implanted under the skin can reprogram the mammalian immune system to attack tumors.</description>
     <link>http://www.physorg.com/news151866192.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 22 Jan 2009 17:03:49 EST</pubDate>
	 <guid isPermaLink="false">news151866192</guid>
</item>
<item>
     <title>Study in mice shows mechanisms behind immune responses to brain tumors</title>
   	 <description>Findings from a study conducted in mice, published in the open access journal PLoS Medicine next week, provide new insights into how an effective immune response to brain tumors could potentially be brought about in humans.</description>
     <link>http://www.physorg.com/news151053609.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 13 Jan 2009 07:20:09 EST</pubDate>
	 <guid isPermaLink="false">news151053609</guid>
</item>
<item>
     <title>'Femtomolar Optical Tweezers' May Enable Sensitive Blood Tests</title>
   	 <description>(PhysOrg.com) -- Cutting-edge `tweezers` are so sensitive that they can feel the tell-tale tug of tiny concentrations of pathogens in blood samples, yet don`t ever need to be sterilized -or even held -as they are ephemeral and weightless. </description>
     <link>http://www.physorg.com/news145799465.html</link>
	 <category>Physics</category>
	 <pubDate>Thu, 13 Nov 2008 11:51:05 EST</pubDate>
	 <guid isPermaLink="false">news145799465</guid>
</item>


</channel>
</rss>

